| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-07 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-06 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
4e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |